Conference
Long-Term Efficacy of Nintedanib is Maintained in Patients With Idiopathic Pulmonary Fibrosis (IPF) Irrespective of Dose: Subgroup Analysis of INPULSIS-ON
Authors
Crestani B; Kolb M; Wallaert B; Quaresma M; Stansen W; Richeldi L
Volume
195
Pagination
pp. a5408-a5408
Publication Date
January 1, 2017
DOI
10.1164/ajrccm-conference.2017.195.1_meetingabstracts.a5408
Conference proceedings
American Journal of Respiratory and Critical Care Medicine
Issue
Supplement_1
ISSN
1073-449X
